Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing study sites by state (Alabama through Wisconsin) with revision tag v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:19:18.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The Publications section wording was updated to note that PubMed entries are automatically filled and may not all pertain to the study, and the Revision label was updated to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-24T21:20:24.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Deleted the general notice about a lapse in government funding and potential delays in updates. The study details and links on the page remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-17T18:52:28.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Core study details and eligibility criteria appear unchanged; only minor layout/visual adjustments are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T13:04:52.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operational details (affecting perceived reliability and response capabilities). - Updated version to v3.2.0, removing the previous v3.1.0 tag.
    Difference
    1%
    Check dated 2025-10-05T22:47:02.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Shift from biology-focused topics to economics and taxes, with an updated revision to v3.1.0 and removal of numerous biology-related subjects (e.g., proteins, neoplasms) replaced by economics-focused content.
    Difference
    0.6%
    Check dated 2025-09-28T19:28:29.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.